Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study

This article has been updated


In a prospective study of 23 995 Japanese women, short sleep duration was associated with higher risk of breast cancer (143 cases), compared with women who slept 7 h per day, the multivariate hazard ratio of those who slept 6 h per day was 1.62 (95% confidence interval: 1.05–2.50; P for trend=0.03).


Breast cancer is the commonest cancer in women, worldwide (Parkin et al, 2005). In Japan, the incidence rate age-standardised to the world population was 28.3 per 100 000 in 1991 and 39.5 in 2001 (The Research Group for Population-based Cancer Registration in Japan, 1998; Marugame et al, 2007).

Melatonin, which is secreted mainly from the pineal gland and plays a role in sleep duration, is suggested as an agent in the association between sleep duration and breast cancer (Brzezinski, 1997; Schernhammer and Schulmeister, 2004). This is because melatonin suppresses the synthesis and secretion of sex hormones by promoting the release of gonadotropin-releasing hormone (Martin and Klein, 1976; Aleandri et al, 1996). In relation to melatonin secretion, there have been several observational studies on night work or visual impairment and breast cancer (Feychting et al, 1998; Verkasalo et al, 1999; Kliukiene et al, 2001; Schernhammer et al, 2001; Megdal et al, 2005; Pukkala et al, 2006; Schwartzbaum et al, 2007). In addition, there have been three prospective cohort studies of sleep duration and the risk of breast cancer, although with inconsistent findings (Verkasalo et al, 2005; Pinheiro et al, 2006; Wu et al, 2008).

We therefore examined the association between sleep duration and the risk of breast cancer in a population of Japanese women.

Materials and methods

Details of the Ohsaki National Health Insurance (NHI) Cohort Study have been described previously (Tsuji et al, 1998; Kuriyama et al, 2006). Briefly, this prospective cohort study, started in 1994, included 28 515 women aged 40–79 years living in the 14 municipalities of Miyagi Prefecture, northeastern Japan. The response rate was 95.0% (N=27 134) for the questionnaire, including items on sleep duration and other health-related lifestyle factors. The study protocol was reviewed and approved by the ethics committee of Tohoku University School of Medicine.

After exclusion of participants who had withdrawn from the NHI before follow-up, those who had history of cancer, those who had omitted responses for sleep duration, and those who had reported sleep duration of less than 4 h or more than 12 h, 23 995 participants remained. To follow up participants for mortality and migration, we reviewed the NHI withdrawal history files for 1995–2003. Through the Miyagi Prefectural Cancer Registry, we identified 143 incident cases of breast cancer.

With regard to the sleep duration, participants answered the mean integer number of hours of sleep per day during the last year. Because of the small number who slept for less than 7 h and less than 8 h, we categorised sleep duration into four groups: 6, 7, 8, and 9 h per day. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) of breast cancer incidence according to sleep duration, using the Cox proportional hazards model, with adjustment for age and potential confounders. The continuous P for trend was calculated by treating sleep duration as a continuous variable, and the categorical P for trend by treating each category as a continuous variable. Interactions between the risk and all confounders were tested through the addition of cross-product terms to multivariate model.

All statistical analyses were performed using SAS statistical software, version 9.1 (SAS Institute Inc, Cary, NC, USA), and all those reported were two-sided; differences at P-values of <0.05 were accepted as significant.


Table 1 shows the baseline characteristics of participants according to sleep duration. Participants who slept 6 h or less were more likely to have a family history of cancer, to have used oral contraceptive drugs, and to be premenopausal. Participants who slept 9 h or more were older, had a smaller total caloric intake, lower educational level, were more likely to have a history of diseases, and were less likely to be employed, married, and premenopausal.

Table 1 Baseline characteristics of the participants according to sleep duration

Using women who slept 7 h as the reference group, we found an inverse association between sleep duration and breast cancer risk. The HR of women who slept 6 h or less was 1.62 (95% CI: 1.05–2.50), of those who slept 8 h was 1.14 (95% CI: 0.75–1.73), and of those who slept 9 h or more was 0.72 (95% CI: 0.36–1.43) (P for trend=0.03). This result did not change substantially when participants whose event occurred within 3 years of baseline (N=49) were excluded and stratified analysis by age and menopausal status (Table 2). In addition, we examined in detail confounding and effect modification by other covariates on the associations between sleep duration and the risk of breast cancer. No statistically significant interaction was observed between sleep duration and other confounding factors for the risk of breast cancer on a multiplicative scale (data not shown).

Table 2 Cox proportional hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer incidence according to sleep duration in Japanese women


This study revealed an inverse association between sleep duration and the risk of breast cancer in Japanese women, participants who slept 6 h or daily having a significantly increased risk of breast cancer.

There have been three prospective cohort studies of breast cancer in relation to sleep duration (Verkasalo et al, 2005; Pinheiro et al, 2006; Wu et al, 2008), of which the last two reported a significantly decreased risk in long sleepers and our results are consistent with these. By contrast, another study reported no such association (Pinheiro et al, 2006), possibly studied because residential nurses were studied with rotating-shift work and varying timing of sleep, so that generalising from their results may be inappropriate.

Melatonin is suggested to be involved in this relationship with sleep duration, a decrease that results in a shorter duration of nocturnal melatonin secretion (Wehr, 1991). A lower melatonin level was associated with an increased risk of breast cancer (Schernhammer and Hankinson, 2005; Schernhammer et al, 2008). Melatonin may have an inhibitory effect on gonadal function, including the synthesis and secretion of sex hormones, by promoting the release of gonadaotropin-releasing hormone (Martin and Klein, 1976; Aleandri et al, 1996); it also exerts an antiproliferative effect on breast cancer cell lines (Blask et al, 1997).

Our study had several strengths. First, we recruited participants from the general population, allowing possible generalisation of our results. Second, the Miyagi Prefectural Cancer Registry is one of the earliest and most accurate population-based cancer registries in Japan (Takano and Okuno, 1997), with only 2.7% of breast cancer cases ascertained by death certificate only (DCO) in 1998–2002 (Curado et al, 2007).

Our study also had several methodological limitations. First, we used self-reported sleep duration, and the assessment was done only once. Second, we had no information on such factors as sleep quality, the timing of sleep, the use of sleep medication, or the presence of sleeping disorders that can influence sleep duration and thereby might affect breast cancer risk. Finally, we had no information about rotating-shift work or night work, but since 23% of our participants were housewives, 19.0% farmers, and 15.7% retired, such details would have been unlikely to have changed the result substantially.

In conclusion, we have found a significant inverse association between sleep duration and breast cancer risk in Japanese women, those who slept 6 h or less having a significantly increased risk.

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication


  1. Aleandri V, Spina V, Morini A (1996) The pineal gland and reproduction. Hum Reprod Update 2: 225–235

    CAS  Article  Google Scholar 

  2. Blask DE, Wilson ST, Zalatan F (1997) Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res 57: 1909–1914

    CAS  PubMed  Google Scholar 

  3. Brzezinski A (1997) Melatonin in humans. N Engl J Med 336: 186–195

    CAS  Article  Google Scholar 

  4. Curado M, Edwards B, Shin H, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents, Vol IX In IARC Scientific Publications IARC: Lyon

    Google Scholar 

  5. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9: 490–494

    CAS  Article  Google Scholar 

  6. Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84: 397–399

    CAS  Article  Google Scholar 

  7. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296: 1255–1265

    CAS  Article  Google Scholar 

  8. Martin JE, Klein DC (1976) Melatonin inhibition of the neonatal pituitary response to luteinizing hormone-releasing factor. Science 191: 301–302

    CAS  Article  Google Scholar 

  9. Marugame T, Matsuda T, Kamo K, Katanoda K, Ajiki W, Sobue T (2007) Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol 37: 884–891

    Article  Google Scholar 

  10. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES (2005) Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41: 2023–2032

    Article  Google Scholar 

  11. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108

    Article  Google Scholar 

  12. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66: 5521–5525

    CAS  Article  Google Scholar 

  13. Pukkala E, Ojamo M, Rudanko SL, Stevens RG, Verkasalo PK (2006) Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control 17: 573–576

    Article  Google Scholar 

  14. Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schunemann HJ, Strano S, Muti P (2008) Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100: 898–905

    CAS  Article  Google Scholar 

  15. Schernhammer ES, Hankinson SE (2005) Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97: 1084–1087

    CAS  Article  Google Scholar 

  16. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563–1568

    CAS  Article  Google Scholar 

  17. Schernhammer ES, Schulmeister K (2004) Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer 90: 941–943

    CAS  Article  Google Scholar 

  18. Schwartzbaum J, Ahlbom A, Feychting M (2007) Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33: 336–343

    Article  Google Scholar 

  19. Takano A, Okuno Y (1997) Japan, Miyagi Prefecture. In: International Agency for Research on Cancer, Parkin D, Whelan S, Ferlay J, Raymond L, Young J (eds) Vol. 17, pp 386–389. IARC: Lyon

  20. The Research Group for Population-based Cancer Registration in Japan (1998) Cancer incidence in Japan in 1991: estimates based on data from population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan (5–3). Jpn J Clin Oncol 28: 574–577

    Article  Google Scholar 

  21. Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K, Watanabe Y, Tsubono Y, Bando T, Kanemura S, Izumi Y, Sasaki A, Fukao A, Nishikori M, Hisamichi S (1998) A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol 8: 258–263

    CAS  Article  Google Scholar 

  22. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65: 9595–9600

    CAS  Article  Google Scholar 

  23. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80: 1459–1460

    CAS  Article  Google Scholar 

  24. Wehr TA (1991) The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab 73: 1276–1280

    CAS  Article  Google Scholar 

  25. Wu AH, Wang R, Koh WP, Stanczyk FC, Lee HP, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29 (6): 1244–1248

    CAS  Article  Google Scholar 

Download references


This study was supported by a Grant-in-Aid for Cancer Research and for the Third Term Comprehensive Ten-Year Strategy for Cancer Control (H18-3jigan-ippan-001), Ministry of Health, Labour and Welfare, Japan. Masako Kakizaki was supported in part by Global COE Program (Basic and Translational Research Center for Global Brain Science), MEXT, Japan.

Author information



Corresponding author

Correspondence to M Kakizaki.

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit

Reprints and Permissions

About this article

Cite this article

Kakizaki, M., Kuriyama, S., Sone, T. et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99, 1502–1505 (2008).

Download citation


  • sleep duration
  • breast cancer
  • incidence
  • Japanese
  • prospective cohort study

Further reading